Inhibrx Biosciences Inc. (INBX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.22B |
| Enterprise Value | 1.21B |
| P/E Ratio | -9.78 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 925.98 |
| Price/Book Ratio | -60.79 |
| Enterprise/Revenue | 806.17 |
| Enterprise/EBITDA | -9.03 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -100.14 |
| Operating Margin | -94.65 |
| Return On Assets | -0.71 |
| Return On Equity | -5.64 |
| Revenue | 1.3M |
| Revenue/Share | 0.08 |
| Gross Profit | -1.18M |
| EBITDA | -125.37M |
| Net Income | -140.06M |
| Diluted EPS | -9.04 |
| Total Cash | 161.66M |
| Total Cash/Share | 10.37 |
| Total Debt | 5.9M |
| Total Debt/Equity | -0.28 |
| Current Ratio | 6.46 |
| Book Value Per Share | -1.35 |
| 52-Week Change | 276.38 |
| 52-Week High | 155.29 |
| 52-Week Low | 20.55 |
| Moving Average 50 Days | 93.3 |
| Moving Average 200 Days | 83.79 |
| Average Volume | 380,596 |
| Shares Outstanding | 14.67M |
| % Held by Institutions | 81.58 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |